Literature DB >> 25596066

Paroxysmal tonic upward gaze as a presentation of de-novo mutations in CACNA1A.

Lubov Blumkin1, Esther Leshinsky-Silver2, Marina Michelson3, Ayelet Zerem4, Sara Kivity4, Dorit Lev3, Tally Lerman-Sagie4.   

Abstract

OBJECTIVE: Paroxysmal tonic upward gaze was initially described as a benign phenomenon with negative investigations and eventual complete resolution of symptoms. Later publications demonstrated that a similar clinical picture may arise from structural brain lesions, channelopathies, neurotransmitter disorders, and epileptic seizures. CACNA1A related disorders manifest as a wide spectrum of paroxysmal neurological disorders: episodic ataxia 2, hemiplegic migraine, benign paroxysmal torticollis of infancy, and paroxysmal vertigo. Paroxysmal tonic upward gaze as a phenomenon in patients with mutations in the CACNA1A gene has only been reported once.
METHODS: We describe three patients with multiple episodes of paroxysmal tonic upward gaze that appeared during the first months of life. In addition the patients demonstrated motor and language delay and cerebellar ataxia. A sequence analysis of the CACNA1A gene in one patient and whole exome sequencing in the other patients were performed.
RESULTS: Sequence analysis of the CACNA1A gene in one patient and whole exome sequencing in the two other patients revealed 3 different de-novo mutations in the CACNA1A gene.
CONCLUSION: CACNA1A mutations should be evaluated in infants and young children with paroxysmal tonic upgaze especially if associated with developmental delay, cerebellar signs, and other types of paroxysmal event.
Copyright © 2015 European Paediatric Neurology Society. All rights reserved.

Entities:  

Keywords:  Ataxia; CACNA1A; Paroxysmal tonic upward gaze

Mesh:

Substances:

Year:  2015        PMID: 25596066     DOI: 10.1016/j.ejpn.2014.12.018

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  7 in total

1.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

2.  Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremor.

Authors:  Bryn D Webb; Anthony Evans; Thomas P Naidich; Lynne M Bird; Sumit Parikh; Meilin Fernandez Garcia; Lindsay B Henderson; Francisca Millan; Yue Si; Kristen J Brennand; Peter Hung; Janet C Rucker; Patricia G Wheeler; Eric E Schadt
Journal:  Hum Mutat       Date:  2021-04-15       Impact factor: 4.700

Review 3.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 4.  Paroxysmal tonic upgaze accompanied by occipital discharge on electroencephalography: a case report and literature review.

Authors:  Yan-Feng Zhang; Yi-Zhu Wang; Xiao-Sheng Hao; Hong-Bo Zhang; Jiang-Tao Wang; Jian-Min Liang
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

Review 5.  Episodic Ataxias: Clinical and Genetic Features.

Authors:  Kwang-Dong Choi; Jae-Hwan Choi
Journal:  J Mov Disord       Date:  2016-09-21

Review 6.  Genetic neurological channelopathies: molecular genetics and clinical phenotypes.

Authors:  J Spillane; D M Kullmann; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-11       Impact factor: 10.154

7.  CACNA1A Mutations Causing Early Onset Ataxia: Profiling Clinical, Dysmorphic and Structural-Functional Findings.

Authors:  Antonio F Martínez-Monseny; Albert Edo; Dídac Casas-Alba; Mercè Izquierdo-Serra; Mercè Bolasell; David Conejo; Loreto Martorell; Jordi Muchart; Laura Carrera; Carlos I Ortez; Andrés Nascimento; Baldo Oliva; José M Fernández-Fernández; Mercedes Serrano
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.